360
Participants
Start Date
July 27, 2018
Primary Completion Date
June 29, 2020
Study Completion Date
June 8, 2021
Brolucizumab
Intravitreal injection
Aflibercept
Intravitreal injection
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Bern
Novartis Investigative Site, Alken
Novartis Investigative Site, Roskilde
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Nyíregyháza
Novartis Investigative Site, Zurich
Novartis Investigative Site, Varna
Novartis Investigative Site, Aalborg
Novartis Investigative Site, Berlin
Novartis Investigative Site, Tallinn
Novartis Investigative Site, Prague
Novartis Investigative Site, Bundang Gu
Novartis Investigative Site, Dijon
Novartis Investigative Site, Gaziantep
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Taoyuan District
Novartis Investigative Site, Izmir
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Shah Alam
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Taichung
Novartis Investigative Site, Kocaeli
Novartis Investigative Site, Nantes
Novartis Investigative Site, Petaling Jaya
Novartis Investigative Site, Münster
Novartis Investigative Site, Busan
Novartis Investigative Site, Changhua
Novartis Investigative Site, Tartu
Novartis Investigative Site, Lyon
Novartis Investigative Site, Lyon
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Rouen
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Montauban
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Ulm
Novartis Investigative Site, Trenčín
Novartis Investigative Site, Bobigny
Novartis Investigative Site, Créteil
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Chandigarh
Novartis Investigative Site, El Achrafiyé
Novartis Investigative Site, Singapore
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Cheboksary
Novartis Investigative Site, Chennai
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Coimbatore
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Prague
Novartis Investigative Site, Marseille
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Budapest
Novartis Investigative Site, Szeged
Novartis Investigative Site, Szombathely
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Riga
Novartis Investigative Site, Beirut
Novartis Investigative Site, Beirut
Novartis Investigative Site, Kaunas
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Oslo
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Singapore
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Poprad
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Örebro
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY